Supplementary Table S2 from Endogenous CD4⁺ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic <i>KRAS</i> and <i>ERBB2</i> (<i>Her2</i>) Driver Mutations

Supplementary Table S2